ISRG

Intuitive Surgical, Inc.

$450.04

-2.28%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.

Source: Yahoo Finance
AI summary

Price & performance

1M+10.4%
3M+30.3%
YTD-21.0%
1Y-15.8%
52-week range—
Beta1.12
Full chart and returns against a benchmark

Q-Score

70/ 100

Quality against peers; 50 is the peer median.

Growth65
Risk72
Performance56
Valuation35
Profitability83
Leverage83
Sentiment42
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$10.1B+20.5%
Net income$2.9B+23.0%
Net margin28.4%+0.6 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

ISRGIndustryP/E52.7549.36P/S13.473.73EV/EBITDA39.3923.12P/B9.763.92PEG6.896.89
Dividend yield0.00%
Every valuation metric

Earnings

Jan 21next report, after the close
EPS estimate$2.64
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate